Physician profile
Daniel Morrissy
NPI 1013130020
$338.84
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $59.08 · 2021: $48.81 · 2022: $58.78 · 2024: $30.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $30.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $30.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $82.98 | 2019-2022 | |
| Djo, LLC | $56.63 | 2019-2020 | |
| Dynasplint Systems INC. | $36.12 | 2019 | |
| Amgen INC. | $33.18 | 2019 | |
| Bioventus LLC | $30.20 | 2024 | Durolane |
| Nevro Corp. | $21.67 | 2020 | |
| Avanos Medical | $18.37 | 2022 | |
| Ferring Pharmaceuticals INC. | $17.78 | 2021 | |
| Alexion Pharmaceuticals, INC. | $16.78 | 2019 | |
| Depuy Synthes Sales INC. | $13.91 | 2022 | |
| Pacira Therapeutics, INC. | $11.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Morrissy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.